Epithelial tumor development is the result of altered tissue homeostasis, due to deranged intracellular regulation and escape from the counteracting influences of a normal cellular environment. We plan to continue our work in this area, as it relates to the function of the three TGF-beta isoforms in the skin. Mice with specific knockout mutations of the TGF-beta1, TGF-beta2 and TGF-beta 3 genes have been recently developed. Homozygous TGF-beta 2 and TGF-beta 3 knockout mice die within a few hours after birth. To overcome this problem, we have developed a full-thickness grafting approach. When the skin of the newborn knockouts is grafted onto nude mice, it develops normally and can be maintained on the host for at least 1 year. We will use this approach to address the following questions: 1) TGF-beta control of keratinocyte growth and differentiation in vivo. We will test the hypothesis that the individual TGF-beta isoforms play distinct or only partially overlapping roles on control of keratinocyte growth/differentiation and apoptosis in the intact skin. We will analyze the epidermis of grafts from mice with each of the TGF- beta knockout mutations, as well as wild type controls, under basal conditions and under conditions of altered skin homeostasis, such as after TPA or retinoic acid exposure. 2) TGF-beta control of keratinocyte growth and differentiation in culture. We will complement the in vivo analysis with in vitro studies of cultured kerationocytes derived from both knockout and wild type mice, plus/minus TGF-beta exposure. In this manner, we will determine (1) which are the direct and specific effects of individual TGF-betas on keratinocyte growth, differentiation and apoptosis; (2) which of these effects are due to an autocrine versus paracrine loop. 3) TGF-beta control of skin tumor development. We will investigate the role that the individual TGF-betas play in skin carcinogenesis, with a special emphasis on TGF-beta3. For this purpose, TGF-beta knockout skins grafted onto nude mice will be tested for their rate of benign and malignant tumor formation, in response to a chemical carcinogenesis protocol or after crossing into a ras transgenic background. 4) TGF-beta control of keratinocyte tumorigenicity. The individual TGF-beta factors could play distinct autocrine and/or paracrine functions in control of keratinocyte tumor development. To address this question, we will evaluate (a) keratinocytes derived from TGF-beta knockout mice for their susceptibility to tumorigenic conversion after ras oncogene transformation, and (b) dermal fibroblasts derived from the same mice for their capability to suppress keratinocyte tumor formaiton.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039190-12
Application #
6029951
Study Section
Pathology B Study Section (PTHB)
Program Officer
Moshell, Alan N
Project Start
1988-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Goruppi, Sandro; Jo, Seung-Hee; Laszlo, Csaba et al. (2018) Autophagy Controls CSL/RBPJ? Stability through a p62/SQSTM1-Dependent Mechanism. Cell Rep 24:3108-3114.e4
Al Labban, Dania; Jo, Seung-Hee; Ostano, Paola et al. (2018) Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. J Clin Invest 128:2581-2599
Ă–zdemir, Berna C; Dotto, Gian-Paolo (2017) Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? Trends Cancer 3:181-197
Goruppi, Sandro; Procopio, Maria-Giuseppina; Jo, Seunghee et al. (2017) The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. Cell Rep 20:2468-2479
Kim, Dong Eun; Procopio, Maria-Giuseppina; Ghosh, Soumitra et al. (2017) Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. J Exp Med 214:2349-2368
Dotto, G Paolo; Rustgi, Anil K (2016) Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. Cancer Cell 29:622-637
Lefort, Karine; Ostano, Paola; Mello-Grand, Maurizia et al. (2016) Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer. Oncotarget 7:48011-48026
Jo, Seung-Hee; Kim, Dong Eun; Clocchiatti, Andrea et al. (2016) PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation. Oncotarget 7:58717-58727
Menietti, Elena; Xu, Xiaoying; Ostano, Paola et al. (2016) Negative control of CSL gene transcription by stress/DNA damage response and p53. Cell Cycle 15:1767-78
Procopio, Maria-Giuseppina; Laszlo, Csaba; Al Labban, Dania et al. (2015) Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol 17:1193-204

Showing the most recent 10 out of 73 publications